Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grups

Publicacions

  • Mota, A; Oltra, SS; Selenica, P; Moiola, CP; Casas-Arozamena, C; Lopez-Gil, C; Diaz, E; Gatius, S; Ruiz-Miro, M; Calvo, A; Rojo-Sebastian, A; Hurtado, P; Piñeiro R; Colas, E; Gil-Moreno, A; Reis-Filho, JS; Muinelo-Romay, L; Abal, M; Matias-Guiu, X; Weigelt, B; Moreno-Bueno, G

    Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression.

    ONCOGENE 41 1835-1850. .

    [doi:10.1038/s41388-022-02221-0]

  • MATIAS-GUIU GUIA, XAVIER

    Prevención secundaria de cáncer de cuello de útero, 2022. Conducta clínica ante resultados anormales de las pruebas de cribado

    Prevención secundaria del cancer de cuello de útero, 2022. Conducta clínica ante resultados anormales de las pruebas de cribado. -. .

  • MORENO, S; MAIQUES, O; Romero M; Santacana M; Gómez I; Cuevas D; Velasco A; Veà À; Macià A; Barceló C; BOIX, R; VALLS, J; GATIUS, S; CANTI, C; MATIAS-GUIU, X; SORIA, X; MARTI, RM

    Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.

    ACTA DERMATO-VENEREOLOGICA 101 -. .

    [doi:10.2340/actadv.v101.361]

  • Rofes P; González S; Navarro M; Moreno-Cabrera JM; Solanes A; Darder E; Carrasco E; Iglesias S; Salinas M; Gómez C; Velasco À; Tuset N; Varela M; Llort G; Ramon Y Cajal T; Grau È; Dueñas N; de la Ossa Merlano N; Matías-Guiu X; Rivera B; Balmaña J; Pineda M; Brunet J; Capellá G; Del Valle J; Lázaro C

    Paired Somatic-Germline Testing of 15 Polyposis and Colorectal Cancer-Predisposing Genes Highlights the Role of APC Mosaicism in de Novo Familial Adenomatous Polyposis.

    Journal Of Molecular Diagnostics 23 1452-1459. .

    [doi:10.1016/j.jmoldx.2021.07.024]

  • Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM

    BRAF(V600E)

    Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

    Cancers 13 -. .

    [doi:10.3390/cancers13205073]

  • Eritja N; Navaridas R; Ruiz-Mitjana A; Vidal-Sabanés M; Egea J; Encinas M; Matias-Guiu X; Dolcet X

    Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation

    Cancers 13 -. .

    [doi:10.3390/cancers13194990]

  • Manning-Geist BL; Gatius S; Liu Y; Gil M; Da Cruz Paula A; Tuset N; Abu-Rustum NR; Aghajanian C; Weigelt B; Matias-Guiu X

    Diagnosis and management of an endometrial cancer patient with Cowden syndrome.

    GYNECOLOGIC ONCOLOGY 163 14-21. .

    [doi:10.1016/j.ygyno.2021.08.008]

  • Guerra E; Matias-Guiu X

    Relevance of pathologic features in risk stratification for early-stage endometrial cancer.

    Journal of Gynecologic Oncology 32 -. .

    [doi:10.3802/jgo.2021.32.e67]

  • Concin N; Matias-Guiu X; Creutzberg CL; ESGO-ESTRO-ESP Endometrial Carcinoma Guideline Working Group

    Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 947-947. .

    [doi:10.1136/ijgc-2021-002668]

  • Buza N; Euscher ED; Matias-Guiu X; McHenry A; Oliva E; Ordulu Z; Parra-Herran C; Rottmann D; Turner BM; Wong S; Hui P

    Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study.

    Modern Pathology 34 1194-1202. .

    [doi:10.1038/s41379-021-00746-5]

  • Gil-Moreno A; Alonso-Alconada L; Díaz-Feijoo B; Domingo S; Vilar A; Hernández A; Gilabert J; Llueca A; Torné A; de Santiago J; Carbonell-Socias M; Lago V; Arias E; Sampayo V; Siegrist J; Chipirliu A; Sánchez-Iglesias JL; Pérez-Benavente A; Padilla-Iserte P; Santacana M; Matias-Guiu X; Abal M; Lopez-Lopez R

    M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients.

    GYNECOLOGIC ONCOLOGY 161 681-686. .

    [doi:10.1016/j.ygyno.2021.03.022]

  • Devis-Jauregui L; Eritja N; Davis ML; Matias-Guiu X; Llobet-Navàs D

    Autophagy in the physiological endometrium and cancer.

    Autophagy 17 1-19. .

    [doi:10.1080/15548627.2020.1752548]

Projectes

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment